Radius Health, Inc. Contracts & Agreements
211 Contracts & Agreements
- Business Finance (50 contracts)
- Business Operations (33)
- Human Resources (52)
- Intellectual Property (5)
- Mergers & Acquisitions (2)
- Real Estate (11)
- Uncategorized (58)
- Second Supplemental Indenture, dated August 15, 2022, by and between Radius Health, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on August 15, 2022)
- Agreement and Plan of Merger, dated as of June 23, 2022, by and among the Company, Ginger Acquisition, Inc. and Ginger Merger Sub, Inc (Filed With SEC on June 23, 2022)
- Form of Contingent Value Rights Agreement to be entered into between Ginger Acquisition, Inc. and a Rights Agent (Filed With SEC on June 23, 2022)
- Offer Letter between the Company and Mark Conley (Filed With SEC on March 16, 2022)
- License Agreement, dated September 27, 2005, between the Company, as successor to Nuvios, Inc., and Ipsen Pharma SAS (f/k/a SCRAS S.A.S.) on behalf of itself and its affiliates,... (Filed With SEC on August 5, 2021)
- Commercial Supply Agreement, dated June 28, 2016, between the Company and Vetter Pharma International GmbH (Filed With SEC on August 5, 2021)
- License Agreement, dated June 29, 2006, between the Company and Eisai Co., Ltd (Filed With SEC on August 5, 2021)
- Surrender Agreement, dated May 19, 2021, by and between Rovi Corporation and Radius Health, Inc (Filed With SEC on May 21, 2021)
- Radius Health, Inc. Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on May 7, 2021)
- Form of Executive Severance Agreement (Filed With SEC on February 25, 2021)
- General Release of Claims, dated December 15, 2020, between the Company and Charles Morris (Filed With SEC on February 25, 2021)
- Consulting Agreement, dated December 15, 2020, between the Company and Charles Morris (Filed With SEC on February 25, 2021)
- Asset Purchase Agreement, dated December 30, 2020, between Radius Pharmaceuticals, Inc. Benuvia Therapeutics Inc. and Fresh Cut Development LLC (Filed With SEC on February 25, 2021)
- License Agreement, dated as of July 23, 2020, by and between the Company and Berlin-Chemie AG (Filed With SEC on November 5, 2020)
- Partial Release and Acknowledgement Agreement, dated as of July 23, 2020, by and between the Company and MidCap Financial Trust (Filed With SEC on November 5, 2020)
- General Release of Claims, dated as of September 22, 2020, by and between the Company and Jose (Pepe) Carmona (Filed With SEC on November 5, 2020)
- Employment Agreement between the Company and G. Kelly Martin (Filed With SEC on April 28, 2020)
- Inducement Option Agreement (Time-Based Option) between the Company and G. Kelly Martin (Filed With SEC on April 28, 2020)
- Inducement Option Agreement (Performance-Based Option) between the Company and G. Kelly Martin (Filed With SEC on April 28, 2020)
- Senior Advisor Agreement between the Company and Jesper Hoeiland (Filed With SEC on April 28, 2020)
- Amendment No. 1, dated as of March 27, 2020, to Credit and Security Agreement (Term Loan), dated January 10, 2020, by and among Radius Health, Inc., a Delaware corporation, Radius... (Filed With SEC on March 30, 2020)
- Description of Securities (Filed With SEC on February 27, 2020)
- Amendment No. 1, dated December 1, 2019, to Commercial Supply Agreement, dated June 28, 2016, between the Company and Vetter Pharma International GmbH (Filed With SEC on February 27, 2020)
- Fourth Amendment, dated January 28, 2020, to Lease, dated May 14, 2014, between the Company and BP Bay Colony LLC (Filed With SEC on February 27, 2020)
- Form of Restricted Stock Unit Agreement for Employees under Radius Health, Inc. 2018 Stock Option and Incentive Plan (Filed With SEC on February 27, 2020)
- Amendment No. 1, dated February 7, 2017, to the Supply Agreement, dated June 23, 2016, between the Company and Ypsomed AG (Filed With SEC on August 7, 2019)
- Amendment No. 2, dated June 18, 2019, to Supply Agreement, dated June 23, 2016, between the Company and Ypsomed AG (Filed With SEC on August 7, 2019)
- Amendment No. 2, dated June 10, 2019, to the Manufacturing Services Agreement, dated July 13, 2016, between the Company and Polypeptide Laboratories Holding (PPL) AB, as successor... (Filed With SEC on August 7, 2019)
- Amendment No. 1 to Manufacturing Services Agreement, dated July 13, 2016, between the Company and Polypeptide Laboratories Holding (PPL) AB, as successor to Lonza Sales Ltd (Filed With SEC on May 8, 2019)
- Radius Health, Inc. Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on February 28, 2019)
- Employment Letter Agreement, dated June 28, 2018, between the Company and Charles Morris (Filed With SEC on February 28, 2019)
- Form of Indemnification Agreement between the Company and its Directors (Filed With SEC on February 28, 2019)
- Form of Indemnification Agreement between the Company and its Officers (Filed With SEC on February 28, 2019)
- Employment Inducement Stock Option Agreement, dated September 4, 2018, between the Company and Charles Morris (Filed With SEC on February 28, 2019)
- Separation Agreement and General Release of Claims, dated September 19, 2018, between the Company and Gary Hattersley (Filed With SEC on November 1, 2018)
- Consulting Agreement, dated September 19, 2018, between the Company and Gary Hattersley (Filed With SEC on November 1, 2018)
- Third Amendment, dated May 23, 2018, to Lease, dated May 14, 2014, between the Company and BP Bay Colony LLC (Filed With SEC on August 7, 2018)
- Separation Agreement and General Release of Claims, dated May 31, 2018, between the Company and Gregory Williams (Filed With SEC on August 7, 2018)
- Consulting Agreement, dated May 31, 2018, between the Company and Williver Associates LLC (Filed With SEC on August 7, 2018)
- Radius Health, Inc. Form of Employment Inducement Stock Option Agreement (Filed With SEC on August 7, 2018)
- Radius Health, Inc. 2018 Stock Option and Incentive Plan, together with forms of Incentive Stock Option Agreement, Non-Qualified Stock Option Agreement for Employees,... (Filed With SEC on August 7, 2018)
- Scale-Up and Commercial Supply Agreement, dated February 27, 2018, between the Company, 3M Company and 3M Innovative Properties Company (Filed With SEC on May 10, 2018)
- Second Amendment, dated April 22, 2016, to Lease, dated May 14, 2014, between the Company and BP Bay Colony LLC (Filed With SEC on May 10, 2018)
- Radius Health, Inc. Amended and Restated Non-Employee Director Compensation Program (Filed With SEC on March 1, 2018)
- Employment Letter Agreement, dated November 10, 2017, between the Company and Joseph Kelly (Filed With SEC on March 1, 2018)
- Form of Executive Severance Agreement between the Company and Joseph Kelly (Filed With SEC on March 1, 2018)
- Employment Inducement Stock Option Agreement, dated November 27, 2017, between the Company and Joseph Kelly (Filed With SEC on March 1, 2018)
- First Amendment to Employment Agreement between the Company and Jesper Hiland (Filed With SEC on November 16, 2017)
- License and Development Agreement, dated July 13, 2017, between the Company and Teijin Limited (Filed With SEC on November 2, 2017)
- Amended and Restated First Amendment to Sublease, dated August 1, 2017, between the Company and Rovi Corporation (Filed With SEC on November 2, 2017)
- RADIUS HEALTH, INC., Issuer AND WILMINGTON TRUST, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of August 14, 2017 Senior DebtSecurities TABLE OF CONTENTS1 (Filed With SEC on August 14, 2017)
- RADIUS HEALTH, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTALINDENTURE Dated as of August 14, 2017 to Indenture Dated as ofAugust 14, 2017 3.00%... (Filed With SEC on August 14, 2017)
- Radius Health, Inc. 3.00%Convertible Senior Notes due September 1, 2024 Underwriting Agreement (Filed With SEC on August 9, 2017)
- LEASE between KBSIII CROSSPOINT AT VALLEY FORGE TRUST, as Landlord and RADIUS HEALTH, INC., as Tenant 550 E. Swedesford Road Wayne, Pennsylvania June 28, 2017 (Filed With SEC on August 4, 2017)
- SUBLEASE dated as of As of March 11, 2016 between ROVI CORPORATION, Sublandlord and RADIUS HEALTH, INC., Subtenant (Filed With SEC on August 4, 2017)
- FIRST AMENDMENT TO SUBLEASE (Filed With SEC on August 4, 2017)
- Employment Agreement (Filed With SEC on July 17, 2017)
- Radius Health, Inc. Employment Inducement Stock Option Agreement (Filed With SEC on July 17, 2017)
- AGREEMENT AND GENERAL RELEASE (Filed With SEC on July 17, 2017)
- Radius Health, Inc. Employment Inducement Stock Option Agreement (Filed With SEC on May 15, 2017)
- Option Type (Filed With SEC on May 15, 2017)
- CONSULTING AGREEMENT (Filed With SEC on May 15, 2017)
- FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2017)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on February 24, 2017)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on February 24, 2017)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE (Filed With SEC on February 24, 2017)
- RADIUS HEALTH, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on February 24, 2017)
- EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on February 24, 2017)
- Manufacturing Services Agreement (the Agreement) (Filed With SEC on November 3, 2016)
- SUPPLY AGREEMENT effective as of September 30, 2015 ("Effective Date") between (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 (Filed With SEC on August 4, 2016)
- QUALITY AGREEMENT for the Manufacture of an application system pre-filled with abaloparatide in a solution, by and between RADIUS HEALTH, INC. and VETTER PHARMA-FERTIGUNG GMBH &... (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 29 (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 30 (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 31 (Filed With SEC on August 4, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 32 (Filed With SEC on August 4, 2016)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN (AS AMENDED AND RESTATED) (Filed With SEC on May 27, 2016)
- RADIUS HEALTH, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE (Filed With SEC on May 27, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Statement of Work To the Agreement between RADIUS HEALTH, INC. (RADIUS) and LONZA Sales AG dated 16 of... (Filed With SEC on May 5, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Statement of Work To the Agreement between RADIUS HEALTH, INC. (RADIUS) and LONZA Sales AG dated 16 of... (Filed With SEC on May 5, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Statement of Work To the Agreement between RADIUS HEALTH, INC. (RADIUS) and LONZA Sales AG dated 16 of... (Filed With SEC on May 5, 2016)
- WORK ORDER NO.2 (Filed With SEC on May 5, 2016)
- AMENDMENT NO.3 to WORK ORDER NO.2 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 4 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 8 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 9 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 10 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 11 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 12 (Filed With SEC on May 5, 2016)
- WORK ORDER NO. 13 (Filed With SEC on May 5, 2016)
- AMENDMENT NO. 4 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on May 5, 2016)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 8 TO WORK STATEMENT NB-1 (Filed With SEC on February 25, 2016)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 4 TO WORK STATEMENT NB-3 (Filed With SEC on February 25, 2016)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 5 TO WORK STATEMENT NB-3 (Filed With SEC on February 25, 2016)
- AMENDMENT NO. 3 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on February 25, 2016)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 11 (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 12 (Filed With SEC on November 5, 2015)
- AMENDMENT N6 TO PHARMACEUTICAL DEVELOPMENT AGREEMENT (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 23 version 2 (Filed With SEC on November 5, 2015)
- FIRST AMENDMENT TO LEASE (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 13 (Filed With SEC on November 5, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 Change Order Form # 26 (Filed With SEC on August 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 8 (Filed With SEC on August 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 9 (Filed With SEC on August 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 WORK ORDER NO. 10 (Filed With SEC on August 6, 2015)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 3 (Filed With SEC on August 6, 2015)
- RADIUS HEALTH, INC. 4,054,054 Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on July 23, 2015)
- EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on July 10, 2015)
- EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on July 10, 2015)
- EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on July 10, 2015)
- EXECUTIVE SEVERANCE AGREEMENT (Filed With SEC on July 10, 2015)
- FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2015)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN (AS AMENDED AND RESTATED) (Filed With SEC on May 11, 2015)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2015)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 6, 2015)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240-24b-2 LICENSE AGREEMENT AMENDMENT NO. 1 (Filed With SEC on May 6, 2015)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 9 TO WORK STATEMENT NB-1 (Filed With SEC on May 6, 2015)
- WARRANT TO PURCHASE SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on March 10, 2015)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on March 10, 2015)
- RADIUS HEALTH, INC. 4,000,000 Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on January 23, 2015)
- RADIUS HEALTH, INC. 2,750,000 Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on October 2, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 6 TO WORK STATEMENT NB-1 (Filed With SEC on August 12, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 7 TO WORK STATEMENT NB-1 (Filed With SEC on August 12, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on July 11, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on July 11, 2014)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on July 11, 2014)
- BAY COLONY CORPORATE CENTER 950 WINTER STREET WALTHAM, MASSACHUSETTS Lease Dated May 14, 2014 (Filed With SEC on May 20, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 5 TO WORK STATEMENT NB-1 (Filed With SEC on May 20, 2014)
- AMENDMENT NO. 3 TO AMENDED AND RESTATED STOCK ISSUANCE AGREEMENT (Filed With SEC on May 20, 2014)
- FIFTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 30, 2014)
- RADIUS HEALTH, INC. [ ] Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on April 25, 2014)
- FIFTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 25, 2014)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN (AS AMENDED) (Filed With SEC on April 21, 2014)
- AMENDMENT NO. 1 TO SERIES B-2 CONVERTIBLE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on April 1, 2014)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 4 TO WORK STATEMENT NB-1 (Filed With SEC on April 1, 2014)
- AMENDMENT NO. 2 TO AMENDED AND RESTATED STOCK ISSUANCE AGREEMENT (Filed With SEC on April 1, 2014)
- Orbit Advisers Limited (Filed With SEC on February 28, 2014)
- FOURTH AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on February 21, 2014)
- AMENDMENT NO. 2 TO DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on February 11, 2014)
- Radius Health, Inc. CONSULTING AGREEMENT (Filed With SEC on February 3, 2014)
- Radius Health, Inc. 201 Broadway, 6th Floor Cambridge, MA 02139 (Filed With SEC on February 3, 2014)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on January 8, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on December 17, 2013)
- [signature page follows] (Filed With SEC on November 29, 2013)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on November 15, 2013)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on November 15, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 15, 2013)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 1 TO WORK STATEMENT NB-2 (Filed With SEC on November 14, 2013)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 3 TO WORK STATEMENT NB-1 (Filed With SEC on November 14, 2013)
- Radius Health, Inc. CONSULTING AGREEMENT (Filed With SEC on July 30, 2013)
- RADIUS HEALTH, INC. 2013 Employee Bonus Plan (Filed With SEC on June 26, 2013)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN (AS AMENDED) (Filed With SEC on June 7, 2013)
- CONSENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 14, 2013)
- THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on April 25, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 (Filed With SEC on March 15, 2013)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 Work Statement NB-2 (Filed With SEC on February 26, 2013)
- Confidential Treatment Requested (Filed With SEC on December 20, 2012)
- RADIUS HEALTH, INC. [ ] Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on October 19, 2012)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 230.406 (Filed With SEC on September 28, 2012)
- Confidential Treatment Requested (Filed With SEC on September 28, 2012)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 230.406 (Filed With SEC on September 28, 2012)
- CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 2 TO WORK STATEMENT NB-1 (Filed With SEC on June 22, 2012)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 4, 2012)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on June 4, 2012)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on June 4, 2012)
- Confidential Treatment Requested (Filed With SEC on May 4, 2012)
- CONSULTING AGREEMENT (Filed With SEC on February 29, 2012)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 Change Order Form # 12 (Filed With SEC on February 29, 2012)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 29, 2012)
- FIRST AMENDMENT TO TRANSITION AGREEMENT (Filed With SEC on February 29, 2012)
- SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on February 17, 2012)
- Confidential Treatment Requested (Filed With SEC on December 30, 2011)
- Confidential Treatment Requested (Filed With SEC on December 21, 2011)
- Confidential Treatment Requested Under 17 C.F.R. 200.80(b)(4) and 240.24b-2 CLINICAL TRIAL SERVICES AGREEMENT AMENDMENT NO. 1 TO WORK STATEMENT NB-1 (Filed With SEC on December 15, 2011)
- RADIUS HEALTH, INC. (Filed With SEC on December 5, 2011)
- TRANSITION AGREEMENT (Filed With SEC on December 5, 2011)
- PROMISSORY NOTE (Filed With SEC on November 23, 2011)
- PROMISSORY NOTE (Filed With SEC on November 23, 2011)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on November 23, 2011)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on November 23, 2011)
- AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 10, 2011)
- RADIUS HEALTH, INC 2011 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 10, 2011)
- AMENDMENT N2 TO PHARMACEUTICAL DEVELOPMENT* AGREEMENT (Filed With SEC on November 9, 2011)
- LABORATORY SERVICES AND CONFIDENTIALITY AGREEMENT* (Filed With SEC on November 9, 2011)
- STOCK ISSUANCE AGREEMENT (Filed With SEC on November 8, 2011)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 7, 2011)
- AMENDMENT NO. 2 TO AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on November 7, 2011)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN (Filed With SEC on November 7, 2011)
- RADIUS HEALTH, INC 2011 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 7, 2011)
- RADIUS HEALTH, INC. 2011 EQUITY INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT (Filed With SEC on November 7, 2011)
- RADIUS HEALTH, INC. 2011 LONG-TERM INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT (Filed With SEC on November 7, 2011)
- AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on October 24, 2011)
- LEASE BY AND BETWEEN BROADWAY HAMPSHIRE ASSOCIATES LIMITED PARTNERSHIP AND RADIUS HEALTH, INC. 201 BROADWAY CAMBRIDGE, MASSACHUSETTS TABLE OF CONTENTS (Filed With SEC on September 30, 2011)
- AMENDED AND RESTATED STOCK ISSUANCE AGREEMENT (Filed With SEC on August 12, 2011)
- LEASE BY AND BETWEEN BROADWAY HAMPSHIRE ASSOCIATES LIMITED PARTNERSHIP AND RADIUS HEALTH, INC. 201 BROADWAY CAMBRIDGE, MASSACHUSETTS TABLE OF CONTENTS (Filed With SEC on August 11, 2011)
- AMENDMENT NO. 1 TO SERIES A-1 CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on June 23, 2011)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on May 27, 2011)
- PROMISSORY NOTE (Filed With SEC on May 27, 2011)
- PROMISSORY NOTE (Filed With SEC on May 27, 2011)
- PROMISSORY NOTE (Filed With SEC on May 27, 2011)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on May 27, 2011)
- WARRANT TO PURCHASE SHARES OF SERIES A-1 CONVERTIBLE PREFERRED STOCK (Filed With SEC on May 27, 2011)
- AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on May 23, 2011)
- CLINICAL TRIAL SERVICES AGREEMENT* (Filed With SEC on May 23, 2011)
- STOCK ISSUANCE AGREEMENT* (Filed With SEC on May 23, 2011)
- AGREEMENT AND PLAN OF MERGER by and among Radius Health, Inc. MPM Acquisition Corp. and RHI Merger Corp. April 25, 2011 (Filed With SEC on April 29, 2011)
- REDEMPTION AGREEMENT (Filed With SEC on April 29, 2011)